Search results :

Verapamil

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: C08DA01

Side effects

Options: Hide MedDRA Preferred Terms ,   display all 35 labels

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Infection Infection 2.7% - 12.1% 2.6% - 6.9% x
Constipation Constipation 2.4% - 11.7% 0.9% - 2.7% x x x x x x x x x x x x x x x x
Upper respiratory tract infection Upper respiratory tract infection 5.4% 4.6% x x x
Influenza Influenza 2.4% - 3.7% 1.7% - 2.6% x
Oedema peripheral Oedema peripheral 1.7% - 3.7% 0% - 0.9% x
Ankle edema x
Dizziness Dizziness 1.2% - 4.7% 0% - 2.7% x x x x x x x x x x x x x x x x x
Syncope postmarketing x x x x x x x x x x x x x x x x x x
Pharyngitis Pharyngitis 1.5% - 3% 0% - 2.6% x
Sinusitis Sinusitis 3% 2.6% x
Dyspepsia Dyspepsia 2.7% 1.7% x x
Rhinitis Rhinitis 2.7% 2.6% x
Hypotension Hypotension postmarketing, 0.7% - 2.5% 0% x x x
Hypotension symptomatic 1.5% x x
Hypotension asymptomatic x x x x x x x x x x x x x x x x
Pain Pain 2.4% 1.7% x x
Headache Headache 1.2% - 12.1% 1.7% - 11.2% x x x x x x x x x x x x x x x x x
Cardiac failure Cardiac failure 1.8% x x x x x x x x x x x x x x x
Pulmonary oedema Pulmonary oedema 1.8% x x x x x x x x x x x x
Oedema Oedema 1.2% - 3% 0% - 3.1% x x x x x x x x x x x x x x x
Asthenia Fatigue 0.6% - 4.5% 3.8% x x x x x x x x x x x x x x x
Asthenia postmarketing, 2% 3.4% x
Fatigue Fatigue 0.6% - 4.5% 3.8% x x x x x x x x x x x x x x x
Nausea Nausea 0.9% - 2.7% 0% - 1.9% x x x x x x x x x x x x x x x x x
Injury Accidental injury 1.5% 0% x
Atrioventricular block Atrioventricular block 0.8% - 1.7% 0% x x x x x x x x x x x x x x x x x x x
Bradycardia Bradycardia 1.2% - 1.4% 0.4% x x x x x x x x x x x x x x x x x
Tachycardia Tachycardia postmarketing, 1% x x
Flushing Flushing 0.8% 0.3% x x x x x x x x x x x x x x x
Abdominal discomfort Abdominal discomfort 0.6% x x x
Distress gastrointestinal postmarketing x x x x x x x x x x x x x x x x x x
Orthostatic hypotension Orthostatic hypotension 0.4% 0.3% x x
Alopecia Alopecia postmarketing x x x x x x x x x x x x x x x x x x
Angina pectoris Angina pectoris postmarketing
Arthralgia Arthralgia postmarketing x x x x x x x x x x x x x x x x x x x
Musculoskeletal discomfort Arthralgia postmarketing x x x x x x x x x x x x x x x x x x x
Myalgia postmarketing x x x
Atrioventricular dissociation Atrioventricular dissociation postmarketing x x x x x x x x x x x x x x x x x x
Hypertrophic cardiomyopathy Hypertrophic cardiomyopathy postmarketing
Idiopathic hypertrophic subaortic stenosis x x x x x x x x x x x x x
Chest pain Chest pain postmarketing x x x x x x x x x x x x x x x x x x
Confusional state Confusional state postmarketing x x x x x x x x x x x x x x x x x x x
Feeling abnormal Confusional state postmarketing x x x x x x x x x x x x x x x x x x x
Contusion Contusion postmarketing x x x x x x x x x x x x x x x x x x
Diarrhoea Diarrhoea postmarketing, 2.4% 1.7% x x x x x x x x x x x x x x x x x
Dyspnoea Dyspnoea postmarketing x x x x x x x x x x x x x x x x
Ecchymosis Ecchymosis postmarketing x x x x x x x x x x x x x x x x x x
Erythema multiforme Erythema multiforme postmarketing x x x x x x x x x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x x x x x x x
Dermatitis Rash postmarketing, 2.4% 2.6% x x x x x x x x x x x x x x x x x x x
Rash Rash postmarketing, 2.4% 2.6% x x x x x x x x x x x x x x x x x x x
Extrapyramidal disorder Extrapyramidal disorder postmarketing x x
Extrapyramidal symptoms postmarketing x x x x x x x x x x
Gingival hyperplasia Gingival hyperplasia postmarketing x x x x x x x x x x x x x x x x x x
Gynaecomastia Gynaecomastia postmarketing x x x x x x x x x x x x x x x x x x
Hyperprolactinaemia Hyperprolactinaemia postmarketing x x x x x x x x x x x x x x x
Hypertension Hypertension postmarketing, 1.7% 2% x
Muscle spasms Cramp muscle postmarketing x x x x x x x x x x x x x x x x x x
Muscle spasms x
Myocardial infarction Myocardial infarction postmarketing
Acute coronary syndrome Myocardial infarction postmarketing
Palpitations Palpitations postmarketing x x x x x x x x x x x x x x x x x x
Paraesthesia Paraesthesia postmarketing, 1% 0% x x x x x x x x x x x x x x x x x x x
Psychotic disorder Psychotic disorder postmarketing x x x x x x x x x x x x x x x x x x
Purpura Purpura postmarketing x x x x x x x x x x x x x x x x x x
Vascular purpura Purpura postmarketing x x x x x x x x x x x x x x x x x x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x x x x x x x
Cerebrovascular accident Cerebrovascular accident postmarketing x x x x x x x x x x x x x x x x x x
Hyperhidrosis Sweating postmarketing x x x x x x x x x x x x x x x x x x
Sweating increased x x
Shock Syncope postmarketing x x x x x x x x x x x x x x x x x x
Syncope Syncope postmarketing x x x x x x x x x x x x x x x x x x
Loss of consciousness Syncope postmarketing x x x x x x x x x x x x x x x x x x
Tinnitus Tinnitus postmarketing x x x x x x x x x x x x x x x x
Urticaria Urticaria postmarketing x x x x x x x x x x x x x x x x x x x x
Vasculitis Vasculitis postmarketing x x x x x x x x x x x x x x x x x
Vomiting Vomiting postmarketing x x x
Dry mouth Dry mouth postmarketing x x x x x x x x x x x x x x x x x x
Atrioventricular block complete Atrioventricular block complete postmarketing x x x x x x x x x x x x x
Myalgia Myalgia postmarketing x x x
Galactorrhoea Galactorrhoea postmarketing x x x x x x x x x x x x x x x x
Hypersensitivity Allergy aggravated postmarketing x x x
Hypersensitivity
Hepatic enzyme increased Hepatic enzyme increased postmarketing, 1.4% 0.8% x x x x x x x x x x x x x x x x x
Erectile dysfunction Erectile dysfunction postmarketing x x x x x x x x x x x x x x x x x x x
Quadriparesis Quadriparesis postmarketing x
Macule Macule postmarketing x x x x x x x x x x x x x x x
Vision blurred Vision blurred postmarketing x x x x x x x x x x x x x x x x x x
Tremor Shakiness postmarketing x x x x x x x x x x x x x x x x x x
Tremor x
Electrocardiogram abnormal Electrocardiogram abnormal postmarketing, 2% 3.4% x
Paralysis Paralysis postmarketing x
Blood prolactin increased Blood prolactin increased postmarketing x
Hyperkeratosis Hyperkeratosis postmarketing x x x x x x x x x x x x x x x x x
Insomnia Insomnia postmarketing x x x x x x x x x x x x x x x x x x x
Ileus Ileus postmarketing x
Intermittent claudication Claudication postmarketing x x x x x x x x x x x x x x x x x x
Somnolence Somnolence postmarketing x x x x x x x x x x x x x x x x x x
Drowsiness x x
Anaphylactic shock Anaphylactic shock x
Angioedema Angioedema x x x
Bronchospasm Bronchospasm x
Cholestasis Cholestasis x
Diplopia Diplopia x x
Cardiac flutter Cardiac flutter x x x x x x x x x
Cardiac arrest Cardiac arrest x
Hepatitis Hepatitis x
Hepatitis symptom x
Jaundice Jaundice x
Laryngospasm Laryngospasm x
Lethargy Lethargy x
Nystagmus Nystagmus x x x
Oligomenorrhoea Oligomenorrhoea x
Ileus paralytic Ileus paralytic x x x x x x x x x x x x x x x x
Petechiae Petechiae x
Pruritus Pruritus x x x
Convulsion Convulsion x x
Sleep disorder Sleep disturbance x
Pollakiuria Pollakiuria x
Vertigo Vertigo x x x x
Depressive symptom Depressive symptom x x
Muscular weakness Muscular weakness
Emotional distress Distress
Discomfort Discomfort
Hepatotoxicity Hepatotoxicity x
Joint swelling Ankle edema x
Hypoaesthesia Numbness of limbs x x
Muscle fatigue Muscle fatigue x x x
Rash maculo-papular Rash maculo-papular
Agitation Hyperkinesia x x
Hyperkinesia Hyperkinesia x x
Sinus arrest Sinus arrest
Feeling cold Coldness x x
Respiratory failure Respiratory failure x
Visual impairment Visual impairment x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Verapamil

Side effects:19
Source:FDA Structured Product Label

VERAPAMIL

Side effects:41
Source:FDA Structured Product Label

VERAPAMIL

Side effects:42
Source:FDA Structured Product Label

VERAPAMIL

Side effects:44
Source:FDA Structured Product Label

VERAPAMIL

Side effects:50
Source:FDA Structured Product Label

VERAPAMIL

Side effects:52
Source:FDA Structured Product Label

VERAPAMIL

Side effects:53
Source:FDA Structured Product Label

VERAPAMIL

Side effects:53
Source:FDA Structured Product Label

VERAPAMIL

Side effects:54
Source:FDA Structured Product Label

VERAPAMIL

Side effects:54
Source:FDA Structured Product Label

VERAPAMIL

Side effects:54
Source:FDA Structured Product Label

Verapamil

Side effects:54
Source:FDA Structured Product Label

VERAPAMIL HYDROCHLORIDE / COVERA-HS

Side effects:55
Source:Health Canada

VERAPAMIL

Side effects:55
Source:FDA Structured Product Label

VERAPAMIL

Side effects:57
Source:FDA Structured Product Label

verapamil

Side effects:57
Source:FDA Structured Product Label

Verapamil hydrochloride / Anpec

Side effects:63
Source:medicines.org.au

VERAPAMIL HYDROCHLORIDE / NU-VERAP SR

Side effects:66
Source:Health Canada

VERAPAMIL HYDROCHLORIDE / VERELAN PM

Side effects:68
Source:FDA

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label